1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Tick-Borne Disease Research Program Therapeutic/Diagnostic Research Award is sponsored by U.S. Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP). This award supports product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life.
Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Nonprofit organizations, small businesses, universities, municipalities, tribal governments, healthcare organizations, school districts. Independent investigators are eligible. Confirm the full requirements in the official notice before applying.
The current listing shows up to $1,325,000 over 3 years. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Applications for Tick-Borne Disease Research Program Therapeutic/Diagnostic Research Award are due October 22, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Tick-Borne Disease Research Program Therapeutic/Diagnostic Research Award is funded by U.S. Department of Defense (DoD), Congressionally Directed Medical Research Programs (CDMRP). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
CDMRP's FY26 portfolio funds 34 programs, and October 2026 is dense with full-application deadlines: PRCRP October 5, PCRP October 7, MRP October 14. Every one of them is gated behind a pre-application that closed months earlier. Here is what that two-step structure actually costs applicants, and how to be inside the gate for FY27.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read articleThe memorandum of agreement was signed August 4 and 5, disclosed by House appropriators on September 3, and runs through 2036. It names no dollar figure. Here is what is actually established, what is still speculation, and what researchers holding or planning NIAID biodefense awards should do before September 30.
Read article